Clinicopathological Risk Factors of Unfavorable Outcomes in Vietnamese Women with Primary Invasive Breast Cancer: A Retrospective Cohort Study
Chau Giang Huynh,Nghiem Xuan Huynh,Bich-Ha Thi Truong,Truc Thanh Thai,Phuong-Thao Thi Doan
DOI: https://doi.org/10.2147/BCTT.S422289
2023-08-02
Breast Cancer: Targets and Therapy
Abstract:Chau Giang Huynh, 1 Nghiem Xuan Huynh, 1 Bich-Ha Thi Truong, 2 Truc Thanh Thai, 3 Phuong-Thao Thi Doan 4 1 Department of Pathology, Hung Vuong Hospital, Ho Chi Minh City, Vietnam; 2 Department of Obstetrics and Gynecology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam; 3 Department of Medical Statistics and Informatics, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam; 4 Department of Pathology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam Correspondence: Truc Thanh Thai, University of Medicine and Pharmacy at Ho Chi Minh City, 217 Hong Bang, Ward 11, District 5, Ho Chi Minh City, Vietnam, Tel +84 908 381 266, Email Background: The rate of unfavorable outcomes, such as recurrence and death, in women with invasive breast cancer varies widely across countries and populations. Identifying those with high-risk profiles is critical so that early detection, prediction, and intervention can be made to improve their survival rate. Therefore, our study evaluated the rate of unfavorable outcomes and its association with clinicopathological characteristics in Vietnamese women with primary invasive breast cancer. Methods: A retrospective open cohort study was conducted on Vietnamese women with invasive breast cancer who underwent a mastectomy and were regularly followed up by the hospitals. Kaplan–Meier method was used to estimate the rate of unfavorable outcomes to take into account the follow-up time of each patient. Univariate and multiple Cox regression analyses were conducted to examine the associations between unfavorable outcomes and clinicopathological characteristics. Results: Among 204 women included in the data analysis, the mean age was 54.4 ± 10.9 years. The majority of patients were diagnosed with early-stage (76.5%) or locally advanced (22.5%) breast cancer. The 5-year rate of unfavorable outcomes was 12.8%, and the 8-year rate was 31.7%. Patients with advanced stages had a higher risk of unfavorable outcomes compared to those with early stages (IA, IIA, T2N1). Patients with lymph node metastases and those with triple-negative molecular classification had significantly higher rates of unfavorable outcomes. Conclusion: Although Vietnamese women with breast cancer have a relatively low rate of unfavorable outcomes compared to other countries, findings from this study emphasize the importance of early detection and underscore the need for targeted interventions for patients with advanced stages, lymph node metastases, and triple-negative breast cancer to optimize their treatment, outcomes, and overall prognosis. Keywords: unfavorable outcomes, invasive breast cancer, high-risk profiles, clinicopathological characteristics, Vietnamese women Breast cancer is the most frequently diagnosed cancer in women worldwide, with about 2.26 million new cases, representing 11.7% of all cancer cases reported in 2020. 1 In the United States, breast cancer accounts for almost 29% of all new cancers in women. 2 While there has been a decline in breast cancer mortality rates in developed countries thanks to increased screening mammography and advances in adjuvant therapies, unfavorable outcomes remain high in many resource-limited countries. Even with advanced treatment strategies, most breast cancer recurs within the first five years of diagnosis, particularly with hormone receptor-negative or HER2-positive disease. The 5-year survival incidence of women in high-income countries with breast cancer of all cancer stages is 85–90%, lower in black women (80%) than in white women and lower in women with hormone receptor-negative tumors than in those with hormone receptor-positive tumors. 3–5 In countries with limited economic and medical resources, 5-year survival rates are relatively low and vary widely across countries. For example, the 5-year survival estimates range from less than 20% survival in Mali to 35–50% in Uganda and 85% in Mauritius. 6,7 Because of the high prevalence of breast cancer, identifying those with high-risk profiles is critical so that early detection, prediction, and intervention can be made to improve their survival rate. Many classical risk indicators, including age, grade, tumor size, nodal involvement, invasion, and metastasis, have been reported in previous studies worldwide. 8–10 However, these clinical characteristics do not cover tumor biological heterogeneity among populations. Recent scientific evidence has shown the potential of immunohistochemistry factors (ER, PR, HER2, Ki- 67, PD-L1) or on H&E slides (TILs). For example, in a study of over 4000 patients with invasive breast -Abstract Truncated-